Santa Ana Bio
Alameda, US · 2 known investors
Santa Ana Bio develops engineered antibodies targeting immune system pathways to treat autoimmune and inflammatory diseases. The company uses precision therapeutics designed to either suppress overactive immune responses or reactivate dormant ones.
BiotechMedical Devices
Founders & leadership
PE
Peter EmtageFounder & CEO
AR
Alexander RudenskyScientific Founder
RF
Richard FlavellScientific Founder
GL
Graham LordScientific Founder
AS
Ansuman SatpathyScientific Founder
Investors · 2
In the news
- Santa Ana Bio emerges from stealth with $168mbioprocessintl.com · 2024
- Santa Ana Bio Raises $168M in Fundingfinsmes.com · 2024
- Santa Ana Bio Launches With $168M, Targets Autoimmune and Inflammatory Diseases - BioSpacebiospace.com · 2024
- Santa Ana Bio Launches With $168 Million to Advance Precision Medicines for Inflammatory Diseases - BioSpacebiospace.com · 2024
- Santa Ana Bio - 2025 Company Profile, Funding & Competitors - Tracxntracxn.com · 2023
- Santa Ana Bio - 2025 Funding Rounds & List of Investors - Tracxntracxn.com · 2023